OCX Insider Trading
Insider Ownership Percentage: 1.58%
Insider Buying (Last 12 Months): $6,675,101.19
Insider Selling (Last 12 Months): $0.00
OncoCyte Share Price & Price History
Current Price: $3.22
Price Change: ▼ Price Decrease of -0.22 (-6.40%)
As of 04/28/2025 05:00 PM ET
OncoCyte Insider Trading History
OncoCyte Institutional Trading History
Data available starting January 2016
OncoCyte Corporation, a precision diagnostics company, focuses on development and commercialization of proprietary tests in the United States and internationally. The company is developing DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies; DetermaCNI, a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients; and VitaGraft, a blood-based solid organ transplantation monitoring test. It also provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. (Bio-Rad) to collaborate in the development and the commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Read More on OncoCyte
Volume
24,160 shs
Average Volume
56,440 shs
Market Capitalization
$92.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.97
Who are the company insiders with the largest holdings of OncoCyte?
OncoCyte's top insider investors include:
- Broadwood Partners, LP (Major Shareholder)
- Patrick W Smith (Major Shareholder)
- Andrea S James (CFO)
- Andrew Arno (Director)
- Alfred D Kingsley (Director)
- Josh Riggs (CEO)
Learn More about top insider investors at OncoCyte.
Who are the major institutional investors of OncoCyte?
Which institutional investors are selling OncoCyte stock?
Within the previous quarter, OCX stock was sold by these institutional investors:
- FNY Investment Advisers LLC